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respectively). In linear regression analysis, age was the only 
independent predictor for cAVI (R2 = 0.239, β = 0.455, 
P = 0.001). Systolic BP was significantly associated with 
baPWV (R2 = 0.225, β = 0.403, P = 0.004).
Conclusions In middle-aged normotensive athletes mara-
thon running and ultra-endurance sports had no negative 
impact on arterial stiffness.
Keywords cardiovascular remodeling · Marathon 
running · normotensive · Atherosclerosis · Pulse wave 
velocity
Abbreviations
A-wave  late diastolic filling velocity
baPWV  Brachial-ankle pulse wave velocity
BMI  Body mass index
BP  Blood pressure
cAVI  cardio-ankle vascular index
cV  cardiovascular
e′  Peak septal mitral annular velocity
E-wave  Peak early filling velocity
lV  left ventricular
PWV  Pulse wave velocity
Introduction
the benefits of regular physical activity on atherosclerotic 
disease and cardiovascular (cV) mortality have been well 
established in humans (thompson et al. 2003). there is an 
ongoing debate on adverse cV health effects of chronic 
extreme exercise in humans (O’Keefe and lavie 2013; 
O’Keefe et al. 2012, 2013) triggered by the growing inter-
est for ultra-endurance events in the middle-aged popula-
tion (Knechtle et al. 2012; Stiefel et al. 2012). this has 
Abstract 
Purpose Marathon running has been linked with higher 
arterial stiffness. Blood pressure is a major contributor to 
pulse wave velocity (PWV). We examined indices of arte-
rial stiffness with a blood pressure-independent method in 
marathon runners and ultra-endurance athletes.
Methods Male normotensive amateur runners were allo-
cated to three groups according to former participation in 
competitions: group I (recreational athletes), group II (mar-
athon runners) and group III (ultra-endurance athletes). 
Indices of arterial stiffness were measured with a non-inva-
sive device (VaSera VS-1500n, Fukuda Denshi, Japan) to 
determine the cardio-ankle vascular index (cAVI, primary 
endpoint) and brachial-ankle PWV (baPWV). lifetime 
training hours were calculated. cumulative competitions 
were expressed as marathon equivalents. linear regression 
analysis was performed to determine predictors for cAVI 
and baPWV.
Results Measurements of arterial stiffness were per-
formed in 51 subjects (mean age 44.6 ± 1.2 years): group 
I (n = 16), group II (n = 19) and group III (n = 16). no 
between-group differences existed in age, anthropomet-
ric characteristics and resting BP. cAVI and baPWV were 
comparable between all groups (P = 0.604 and P = 0.947, 
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resulted in increased participation rates of the age group 
>40 years in sports events such as Ironman triathlon, mara-
thon and 100 km ultra-marathon (Knechtle et al. 2012; 
lepers and cattagni 2012; Stiefel et al. 2012). Since a rea-
sonable number of master athletes start exercising vigor-
ously later in life and cV risk factors are already present 
(De Matos et al. 2011), it is essential to evaluate their cV 
risk profile.
there is clear evidence for structural remodeling 
(increase in arterial lumen size and decrease in wall thick-
ness) of central arteries associated with endurance train-
ing (DeVan and Seals 2012; green et al. 2012; Schmidt-
trucksäss et al. 2000). Endurance athletes exhibit a more 
favorable vascular phenotype and higher central arterial 
compliance compared to their sedentary and/or recrea-
tionally active controls (DeVan and Seals 2012; tanaka 
et al. 1998, 2000; Vaitkevicius et al. 1993). While the 
impact of endurance training on central arterial compli-
ance is unequivocal among studies (DeVan and Seals 
2012; tanaka et al. 1998, 2000; Vaitkevicius et al. 1993), 
the influence on peripheral arteries is less consistent (Burr 
et al. 2013; nualnim et al. 2011; tanaka et al. 1998; Vla-
chopoulos et al. 2010b).
Arterial stiffness is a widely recognized surrogate 
marker for atherosclerotic changes of the vascular walls 
and associated with increased cV events and all-cause 
mortality (laurent et al. 2006; Vlachopoulos et al. 2010a). 
two recent studies, employing the principle of applanation 
tonometry, revealed higher arterial stiffness in marathon 
(Vlachopoulos et al. 2010b) and ultra-marathon runners 
(Burr et al. 2013). consequently, the notion has been raised 
that long-term strenuous exercise may have a deleterious 
effect on the vascular system. However, it has to be stressed 
that the applied methods to determine arterial stiffness in 
the two previous studies are blood pressure (BP) depend-
ent and may therefore introduce potential confounding 
(Burr et al. 2013; Vlachopoulos et al. 2010b). In the study 
by Vlachopoulos et al. (2010b), compared to control sub-
jects, marathon runners had a significantly higher BP, and 
the difference in pulse wave velocity (PWV) disappeared 
after adjustment for BP. recently, a new and BP-independ-
ent method was introduced to measure arterial stiffness 
(Shirai et al. 2006, 2011). the stiffness parameter called 
cardio-ankle vascular index (cAVI) has been shown to cor-
relate with cV risk factors (Kubozono et al. 2007) and pre-
dicts severity of coronary atherosclerosis (nakamura et al. 
2008). therefore, we aimed at assessing the impact of high-
volume long-term endurance training on indices of arterial 
stiffness in marathon runners and ultra-endurance athletes 
using this BP-independent method. We hypothesized that 
recreational athletes, marathon runners and ultra-endurance 
athletes would exhibit no differences in the cAVI (primary 
endpoint).
Methods
Study design and participants
We recruited nonelite, male marathon runners by an 
open invitation letter as part of the grand Prix of Bern, 
a 10-mile race in Switzerland with >25,000 participants. 
All athletes applied by electronic mail. We excluded sub-
jects with hypertension (resting BP >140/90 mmHg), 
known hypercholesterinemia and those with a history 
of cV disease except episodes of palpitations or non 
sustained arrhythmias. Additionally, current smokers 
were excluded and pack-years of former smokers were 
assessed. Study participants were randomly selected and 
allocated to three pre-defined groups according to their 
former participations in competitions: group I (recrea-
tional athletes, ≤1 marathon), group II (marathon run-
ners, >1 marathon) and group III (ultra-endurance ath-
letes, 78 and 100 km races, long-distance triathlons). 
Assessment included transthoracic echocardiography, 
24-h ambulatory BP monitoring and measurement of 
arterial stiffness. Before the tests, subjects were asked 
to abstain from food and caffeine-containing substances 
(≥3 h) and alcohol (≥24 h), and they were told to refrain 
from vigorous exercise training for 24 h before the tests. 
A detailed flowchart about subject recruitment and meas-
urements is represented in Fig. 1. All athletes provided 
written informed consent and the protocol was approved 
by the local ethics committee.
Anthropometry and hemodynamic measurements
Body mass was measured with light clothing to the near-
est 0.1 kg using a digital-balanced scale and stature to the 
nearest 0.5 cm using a wall-mounted stadiometer. Body 
mass index (BMI) was calculated as body mass divided by 
stature squared (kg m−2). Body surface area was calculated 
using the DuBois formula (DuBois 1916). resting BP was 
measured three to five times at the right arm after a 10-min 
rest in supine position using VaSera VS-1500n (Fukuda 
Denshi co. ltd, tokyo, Japan). the first measurement was 
excluded and the mean of all other measurements was used 
for data analysis.
Sports history
A comprehensive questionnaire was used to ascertain per-
sonal and sports histories. lifetime training hours were 
calculated using the formula: average endurance and 
strength training hours per week multiplied by 52 mul-
tiplied by training year (Wilhelm et al. 2011). Further-
more, cumulative lifetime competitions were assessed and 
expressed as marathon equivalents: half marathon × 0.5; 
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marathon × 1.0; mountain marathon × 1.2; 78 km 
race × 1.8; Ironman triathlon race × 2.5 and 100 km 
race × 2.5.
Arterial stiffness
Arterial stiffness was measured in supine position using 
a non-invasive and BP-independent device (Shirai et al. 
2011) (VaSera VS-1500n, Fukuda Denshi co. ltd, tokyo, 
Japan). Measurements were performed between 15.00 
and 18.00 p.m. to minimize the potential impact of diur-
nal variation in arterial stiffness. Details of this method can 
be found elsewhere (Shirai et al. 2006). In brief, subjects 
rested for at least 10 min in supine position before the first 
measurement. BP cuffs were placed around each arm and 
ankle and brachial pulse E-waves were detected at a low 
cuff pressure of 30–50 mmHg. A phonocardiogram was 
placed at the right sternal boarder in the second intercostal 
space. the cAVI is automatically calculated by the system 
and reflects the stiffness of the aorta, femoral artery and 
tibial artery. cAVI is determined by the following equa-
tion: cAVI = a{(2ρ/ΔP) × ln(Ps/Pd)PWV2} + b, where 
Ps and Pd are systolic and diastolic BP, PWV is the pulse 
wave velocity between heart and ankle, ΔP is Ps − Pd, ρ 
is blood density, and a and b are constants. the equation 
is derived from the Bramwell–Hill’s equation (Bramwell 
1922) and the stiffness parameter β as defined in Hayashi 
et al. (1975). reproducibility of the device has been dem-
onstrated with a mean coefficient of variation of 3.8 % 
(Shirai et al. 2006). cAVI was measured at least three times 
with 3-min time intervals in-between each measurement. 
the first cAVI measurement was performed to familiar-
ize the subjects with the testing procedure and the result 
was not included in the analysis. In case of a difference 
greater than 0.3 in the cAVI between the second and third 
measurement, another one to two measurements were per-
formed. We took the average of the left and right cAVI and 
used the mean of all measurements, excluding the first, for 
data analysis.
24-h Ambulatory blood pressure
Ambulatory BP monitoring was performed over a 24-h 
period using mobil-0-graph ng® (IEM, Stolberg, ger-
many), a device that has recently been validated and rec-
ommended for clinical use (Wei et al. 2010). the monitor 
and the cuff (nondominant upper arm) was attached by a 
trained physician and a calibration reading was taken to 
ensure accurate readings. the device was programmed to 
measure BP every 15 min during the day and every 30 min 
during the night. BP data were stored in the monitor and 
then downloaded into device-specific computer software 
(Hypertension Management Software, client Server, 4.5., 
IEM, Stolberg, germany). Data were analyzed for the 
Fig. 1  Flowchart about subject 
recruitment, selection and 
measurements
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entire 24-h period and separately for daytime and night-
time. Subjects were allowed to perform exercise training at 
moderate intensities for 60 min on the day of the recording.
transthoracic echocardiography
Standard transthoracic echocardiography was performed 
(X5-1, 1–5 MHz transducer, iE33, Phillips Healthcare, 
Zurich, Switzerland) according to recommendations of the 
European Association of Echocardiography (Evangelista 
et al. 2008). Images were stored digitally and analyzed 
off-line. left ventricular (lV) mass, and end-diastolic and 
end-systolic volumes were calculated according to current 
recommendations and indexed for body surface area (lang 
et al. 2006). lV ejection fraction was derived from end-
diastolic and end-systolic volumes (lang et al. 2006). Pulse 
wave Doppler was performed in the apical four-chamber 
view to obtain peak early filling (E-wave) and late dias-
tolic filling (A-wave) velocities, and peak early filling/late 
diastolic filling velocity ratio. Pulse wave tissue Doppler 
imaging was performed in the apical four-chamber view 
to acquire peak septal mitral annular velocity (e′) (nagueh 
et al. 2009). reproducibility data on cardiac dimensions in 
an athletic population of our laboratory were published pre-
viously (Wilhelm et al. 2012a).
Statistical analysis
Statistical analyses were performed with SPSS for Win-
dows (Version 17.0, SPSS Inc., chicago, USA). the Kol-
mogorov–Smirnov test was used to check data for normal 
distribution. the χ2 test was performed to compare base-
line categorical variables between groups. normally dis-
tributed data were presented as mean ± standard deviation 
(SD), and variables with skewed distribution were shown 
as median (inter-quartile range, IQr). relations between 
variables were evaluated by simple regression analysis. 
Differences in anthropometric characteristics and train-
ing volume between the three groups were evaluated using 
analysis of variance (AnOVA) or Kruskal–Wallis tests, 
as appropriate. Analysis of covariance (AncOVA) mod-
els were applied to detect differences in indices of arterial 
stiffness, echocardiographic, and 24-h BP data between 
groups including lifetime training hours as a covariate. We 
used linear regression models to determine predictors for 
cAVI and baPWV and adjusted for age, lifetime training 
hours and cumulative marathon equivalents and in the lat-
ter variable also for systolic BP. the level of significance 
was set at α = 0.05. Because there are no previous studies 
using cAVI and baPWV in endurance athletes upon which 
a power calculation could be based on, we included all 
volunteering subjects of the 105 invited participants of our 
previous study.
Results
For a related study (in preparation), 208 male athletes 
applied for participation and were classified according to 
the predefined groups. From each group, 35 athletes were 
selected by chance, and a total of 105 athletes were stud-
ied. the 105 subjects were re-invited to the present study 
and 59 volunteered to participate. Eight subjects had to be 
excluded due to reasons as listed in Fig. 1, resulting in 51 
subjects who were included in the present study. there were 
no differences in anthropometric characteristics (table 1) 
and resting BP between the three groups (table 2). Echo-
cardiographic findings revealed no differences in lV mass 
index, lV end-diastolic volume as well as systolic and dias-
tolic function between groups (table 2). Mean systolic BP 
during the 24-h recording and during nighttime was highest 
among ultra-endurance athletes (P = 0.009 and P = 0.018, 
respectively). the 10-mile race time significantly decreased 
from group I to III (P = 0.006). Moreover, compared to 
group I, median lifetime training hours and cumulative 
marathon equivalents were significantly higher in groups 
II and III, respectively, (P < 0.001). there was a tendency 
toward higher training volumes from group I to III in the 
past 3 months (table 1).
Arterial stiffness
cardio-ankle vascular index and baPWV were not differ-
ent between groups I and III (see table 3; Fig. 2). In linear 
regression analysis, age was the only independent predic-
tor for cAVI (R2 = 0.239, β = 0.455, P = 0.001). Systolic 
BP was significantly associated with baPWV (R2 = 0.225, 
β = 0.403, P = 0.004, see table 3). Simple linear regres-
sion analysis revealed no correlation between resting 
systolic BP and cAVI (R2 = 0.035, P = 0.190). Systolic 
BP significantly correlated with baPWV (R2 = 0.164, 
P = 0.004).
Discussion
the main finding of the present study is that in normoten-
sive subjects, a history of many years of very high training 
volume and large number of strenuous competitions, such 
as marathons and ultra-endurance races, were not associ-
ated with increased indices of arterial stiffness compared to 
recreational athletes.
In our study, measures of arterial stiffness (cAVI and 
baPWV) did not differ between ultra-endurance ath-
letes, marathon runners and recreational athletes. this is 
in contrast to previous work (Burr et al. 2013; Vlacho-
poulos et al. 2010b). In the study by Vlachopoulos et al. 
(2010b), exercise volume (min day−1) was an independent 
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determinant of increased arterial stiffness in marathon 
runners who trained on average 15 h week−1 for a mean 
duration of 11 years. In that study, a higher carotid-fem-
oral PWV was found in marathon runners compared to 
recreational athletes. However, BP was also significantly 
higher in the marathon group and, after adjustment for 
BP, the differences in carotid-femoral PWV disappeared. 
We explicitly studied male, normotensive marathon run-
ners and ultra-endurance athletes. resting BP was well 
balanced between the groups, and hypertensive subjects 
(>140/90 mmHg, n = 5) were excluded to avoid bias from 
the effect of BP on arterial stiffness. nevertheless, ultra-
endurance athletes had significantly higher mean systolic 
BP values over the entire 24-h recording and during day- 
and nighttime (8–9 mmHg), confirming that high-inten-
sity activities may predispose to higher BP (Mark and 
Janssen 2008). In another study, Burr et al. (2013) found 
reduced large artery compliance in 18 ultra-marathon run-
ners compared to physically active age-matched controls. 
no differences were observed for small artery compliance 
between the groups and significant relationships between 
years of ultra-marathon and small artery compliance dis-
appeared after adjustment for age. Importantly, multi-
ple linear regression analysis revealed no associations 
between training-related variables and either small or 
large artery compliance. Only in a small subgroup of run-
ners (n = 9), for whom detailed training data were avail-
able, reduced arterial compliance was related to longer 
running distances per training session. the results, how-
ever, should be interpreted with caution due to the low 
sample size studied.
In normotensive middle-aged and older adults, nual-
nim et al. (2011) observed a lower baPWV in runners and 
swimmers compared to sedentary control subjects, despite 
no changes in femoral artery compliance and femoral 
artery stiffness index. the lower baPWV appears to mir-
ror the positive effects of endurance training on arterial 
compliance. Importantly, to eliminate potential deleterious 
effects of chronic physical inactivity on arterial compli-
ance (Schmidt-trucksäss et al. 1999; tanaka et al. 2000), 
we chose a healthy and physically active control group that 
most likely reflects a healthy vascular compliance.
In our study, age was the only significant predictor for 
cAVI, and resting systolic BP was significantly associated 
with baPWV. this is in line with previous work showing 
that both, age and BP are the most powerful and independ-
ent predictors of aortic pulse wave velocity (cecelja and 
chowienczyk 2009).
Table 1  Baseline characteristics of the study population, stratified according to their participation in competitions
Data are expressed as mean ± standard deviation or median (inter-quartile range). ET endurance training, ST strength training. Data were ana-
lyzed using AnOVA or Kruskal–Wallis tests, as appropriate. lifetime training hours were calculated as time spent in endurance plus strength 
training exercises ≥18 years of life)
Variable recreational  
athletes (n = 16)
Marathon  
runners (n = 19)
Ultra-endurance  
athletes (n = 16)
P value
Age (years) 41.0 ± 6.9 46.3 ± 7.9 45.9 ± 9.7 0.158
Height (cm) 178.5 ± 5.9 176.5 ± 5.6 178.0 ± 6.8 0.590
Weight (kg) 71.6 (6.2) 73.3 (8.1) 73.6 (11.5) 0.660
Body mass index (kg m−2) 23.1 ± 3.0 23.3 ± 1.4 23.4 ± 2.2 0.926
Body surface area (m2) 1.9 (0.1) 1.9 (0.2) 1.9 (0.1) 0.589
Former smokers, n (%) 4 (25 %) 4 (21.1 %) 6 (37.5 %) 0.424
training volume
 Exercise training (years) 8 (14.3) 17 (20.0) 15.5 (12.3) 0.072
 Et last 3 months (h week−1) 4.11 ± 2.59 5.11 ± 2.30 7.01 ± 5.07 0.093
 St last 3 months (h week−1) 0.50 ± 0.53 0.35 ± 0.33 0.43 ± 0.46 0.619
 lifetime training (h) 1,508 (2,119) 3,804 (2,548) 4,890 (5,353) 0.008
Participation in competitions
 Ultra-endurance races (n) – – 6.5 (8) <0.001
 Mountain marathons (n) – 1 (3) 2.5 (6) <0.001
 Flat marathons (n) 0 (1) 3 (7) 5.5 (9) <0.001
 Half marathons (n) 2.5 (9) 10 (16) 10 (12) 0.002
 10-mile races (n) 5.5 (8) 10 (11) 15 (20) 0.042
 Marathon equivalents (n) 5.1 (4) 15.8 (19) 31.4 (31) <0.001
Performance
 10-mile race time (h:min) 1:14 ± 0:09 1:08 ± 0:09 1:05 ± 0:07 0.006
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repetitive episodes of arterial shear stress are thought 
to be the main physiological stimulus evoking vascular 
adaptations through endothelium-dependent remodeling 
(tinken et al. 2010). In particular, performing vigorous 
physical activities appears to prevent arterial stiffening 
in the general population (van de laar et al. 2010), and 
according to our data, also in ultra-endurance athletes, 
which reflect a unique population performing intense and 
exhaustive exercise over decades. On the other hand, evi-
dence from cross-sectional studies suggests that long-
term strenuous exercise may indeed accelerate the athero-
sclerotic process (Möhlenkamp et al. 2008). In runners, 
the number of completed marathons was associated with 
coronary artery calcification in otherwise healthy subjects 
(Möhlenkamp et al. 2008). the underlying mechanisms for 
structural changes in vessels are multifactorial and not yet 
fully understood, but inflammatory processes, among oth-
ers, appear to play a pivotal role. Vigorous exercise such 
as marathon running leads to an excessive release of circu-
lating pro-inflammatory cytokines (Bernecker et al. 2013; 
Wilhelm et al. 2012b), oxidative stress (Knez et al. 2007) 
and production of vasoactive substances such as endothe-
lin-1 (Otsuki et al. 2007) that may contribute to structural 
remodeling of small arteries, such as the coronary arteries, 
in the long term. Altogether, the controversial findings from 
different studies investigating arterial stiffness in athletes 
(Burr et al. 2013; Knez et al. 2008; nualnim et al. 2011; 
Vlachopoulos et al. 2010b) may arise from different meth-
odological approaches, e.g.: (a) different measurement 
methods to determine arterial stiffness; (b) single gender 
studies vs. mixed gender studies; (c) inclusion of athletes 
from different disciplines (runners, swimmers, triathletes) 
with different training histories and competition experi-
ence; (d) most importantly, the selection of different con-
trol groups (sedentary vs. active controls).
Some limitations need to be addressed in view of the 
present findings. Our results are based on a small and het-
erogeneous group of endurance-trained athletes. Based on 
the means and standard deviations (power [1 − β] 0.80 
and α = 0.05) of our study, a follow-up study verifying 
our findings would need n = 836 and 15,456 to possess the 
power to detect a between-group difference in baPWV and 
Table 2  comparison between measures of arterial stiffness, echocardiography and 24-h ambulatory blood pressure monitoring data between 
marathon runners, ultra-endurance athletes and recreational athletes
Data are expressed as mean ± standard deviation or median (interquartile range). Data were analyzed using AnOVA or Kruskal–Wallis tests, as 
appropriate. HR heart rate, BP blood pressure, CAVI cardio-ankle vascular index, abPWV brachial-ankle pulse wave velocity, LV left ventricular, 
E/A ratio peak early filling/late diastolic filling velocity ratio, Peak e′ peak septal mitral annular velocity
* Adjusted for lifetime training hours
Variable recreational athletes 
(n = 16)
Marathon runners 
(n = 19)
Ultra-endurance  
athletes (n = 16)
P value
Unadjusted Adjusted*
Arterial stiffness
 Hr at rest (beats min−1) 54.6 ± 8.7 53.9 ± 10.1 55.0 ± 7.9 0.612 0.476
 Systolic BP at rest (mmHg) 124.1 ± 7.8 122.2 ± 8.0 125.9 ± 6.4 0.303 0.333
 Diastolic BP at rest (mmHg) 79.6 ± 6.0 78.9 ± 5.9 78.9 ± 5.8 0.895 0.941
 cAVI 6.78 ± 0.6 6.92 ± 0.7 6.76 ± 0.8 0.757 0.604
 baPWV (m s−1) 11.12 ± 1.1 11.08 ± 1.1 10.98 ± 1.2 1.000 0.947
Echocardiography
 lV mass index (g m−2) 104.6 ± 22.1 100.8 ± 20.6 104.3 ± 14.6 0.745 0.913
 lV end-diastolic volume (ml) 114.6 ± 21.1 110.3 ± 20.6 116.6 ± 17.4 0.631 0.943
 lV ejection fraction (%) 67.3 ± 4.7 64.6 ± 5.8 64.9 ± 3.8 0.254 0.379
 E/A ratio 1.4 (0.7) 1.4 (0.8) 1.6 (0.4) 0.878 0.506
 Peak e′ (cm s−1) 12.3 ± 2.3 11.4 ± 1.2 11.7 ± 1.9 0.376 0.726
24-h Ambulatory BP monitoring
 Mean systolic BP (mmHg) 121.1 ± 7.2 120.8 ± 7.2 128.9 ± 9.8 0.009 0.009
 Mean diastolic BP (mmHg) 79.1 ± 5.9 79.9 ± 4.6 81.6 ± 5.4 0.567 0.173
 Mean systolic BP day (mmHg) 123.7 ± 8.1 123.5 ± 6.9 131.9 ± 10.7 0.009 0.011
 Mean diastolic BP day (mmHg) 81.3 ± 6.2 82.2 ± 4.7 83.4 ± 5.6 0.537 0.150
 Mean systolic  BP night (mmHg) 105.8 ± 5.4 107.0 ± 9.9 114.6 ± 8.9 0.009 0.018
 Mean diastolic BP night (mmHg) 64.6 ± 4.9 67.9 ± 6.4 68.6 ± 6.4 0.139 0.236
 Systolic dipping (%) 14.2 ± 6.0 13.4 ± 5.2 12.9 ± 6.1 0.810 0.949
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cAVI, respectively. this illustrates the minimal clinical rel-
evance of the between-group differences in indices of arte-
rial stiffness. this is further supported by the finding that an 
increase in brachial-ankle elasticity index by 1 m s−1 (com-
pared to a 0.14 m s−1 difference between recreational and 
ultra-endurance athletes) corresponds to a 12 % increase in 
total cV events (Vlachopoulos et al. 2012).
the calculation of the cAVI assumes blood viscosity to 
be constant across subjects. It has to be stressed that there is 
a large variability in blood viscosity among healthy subjects 
(Parkhurst et al. 2012) which could potentially influence 
arterial stiffness measurements. However, recent work by 
Parkhurst et al. (2012) revealed that whole blood viscosity 
does not significantly impact vascular function measures, 
including carotid-femoral PWV and carotid artery compli-
ance in healthy subjects. nevertheless, to which extent inter-
individual differences in blood viscosity impact on cAVI is 
currently unknown and could be a focus of future studies.
Based on the cross-sectional study design, we cannot 
establish causal relationships between training volume and 
indices of arterial stiffness. Moreover, arterial stiffness was 
measured 9 months after the initial assessment. cV risk 
factors may change over time and may potentially impact 
on arterial stiffness. to account for this, we reassessed cV 
risk factors, training history, anthropometric data and rest-
ing BP measurements at the second visit when arterial stiff-
ness was assessed. Moreover, exclusion criteria were based 
on the second examination.
Our data suggest that even long-term participation in 
ultra-endurance sports has no negative impact on indices 
of peripheral arterial stiffness. Physiological adaptations of 
the vasculature to strenuous endurance exercise may result 
from positive stimuli, such as exercise-induced shear stress 
improving elastic properties of arteries as well as positive 
risk factor modification, on the one hand. However, on the 
other hand, long-term vigorous exercise may also lead to 
potentially deleterious mechanisms, such as inflammatory 
processes, vascular oxidative stress and mechanical fatigue 
of the elastic elements of vessels.
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Table 3  Independent predictors 
of arterial stiffness of study 
participants
Multiple linear regression 
analysis on cAVI and baPWV 
and adjusted for age, lifetime 
training hours, cumulative 
number of competitions and 
in the latter case also systolic 
blood pressure. CAVI cardio-
ankle vascular index, BP blood 
pressure, baPWV brachial-ankle 
pulse wave velocity
Beta coefficient Standard error β Standardized β P value
cAVI (R2 = 0.239)
 Age 0.037 0.011 0.455 0.001
 lifetime training hours 0.000 0.000 0.194 0.192
 cumulative competitions −0.007 0.005 −0.210 0.162
baPWV (m s−1) (R2 = 0.225)
 Age 0.022 0.017 0.174 0.210
 Systolic BP 0.059 0.020 0.403 0.004
 lifetime training hours 0.000 0.000 0.136 0.376
 cumulative competitions −0.012 0.008 −0.226 0.144
Fig. 2  comparison of indices 
of arterial stiffness between 
ultra-endurance athletes, 
marathon runners and recrea-
tional athletes. there were no 
differences in cAVI or baPWV 
between groups. baPWV 
brachial-ankle pulse wave 
velocity, CAVI cardio-ankle 
vascular index
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